Super Capital Group
Technology-focused venture capital and growth investment group based in North America. Invests in and supports technology companies across consumer, semiconductor, digital health, and medical device sectors, with experience in sourcing, scaling, and exit execution.
Industries
Nr. of Employees
small (1-50)
Services
Providing seed to growth-stage equity investments for technology companies.
Advisory support for commercialization, scaling, and exit planning.
Providing seed to growth-stage equity investments for technology companies.
Advisory support for commercialization, scaling, and exit planning.
Expertise Areas
- Venture capital investment
- Growth-stage and exit support
- Digital health and medicine AI
- Medical device investments and regulatory assessment
Key Technologies
- AI-driven medicine platforms
- Air disinfection and environmental sterilization technologies
- Switch-capacitor power integrated circuits
- Enterprise software platforms
News & Updates
Announcement of support for an enterprise medicine-AI platform used by healthcare plans and providers to optimize medication treatments, adherence, and performance tracking.
Announcement of support for a supplier of switch-capacitor power integrated circuits for fast charging in mobile devices; company reported shipment volumes exceeding 50 million chips.
Announcement of support for a company offering medical- and commercial-grade air disinfection products; referenced a device described as FDA Cleared Class II and laboratory results showing reduction of a SARS-CoV-2 surrogate.
Announcement of support for an enterprise medicine-AI platform used by healthcare plans and providers to optimize medication treatments, adherence, and performance tracking.
Announcement of support for a supplier of switch-capacitor power integrated circuits for fast charging in mobile devices; company reported shipment volumes exceeding 50 million chips.
Announcement of support for a company offering medical- and commercial-grade air disinfection products; referenced a device described as FDA Cleared Class II and laboratory results showing reduction of a SARS-CoV-2 surrogate.